Science
Scientists use CRISPR-Cas9 to prevent Fuchs’ corneal dystrophy in mice – Medical Xpress
In a new study, researchers at the University of Oregon’s Phil and Penny Knight Campus for Accelerating Scientific Impact used…
In a new study, researchers at the University of Oregon’s Phil and Penny Knight Campus for Accelerating Scientific Impact used start codon disruption with CRISPR-Cas9 gene editing to prevent Fuchs’ corneal dystrophy in mice. It is the first demonstrated…
Continue Reading